• Economic Evaluation of Exemestane Versus Tamoxifen in Post-Menopausal Women with Early Breast Cancer from The Egyptian Health Care System Perspective

    Oct 1, 2017, 00:00

  • A Retrospective Premier Database Study To Compare Repair of Ventral Hernia With Phasixtm VS Stratticetm In The Inpatient Hospital Surgical Setting

    Oct 1, 2017, 00:00

  • Crosslinking to Corneal Keratoconus

    Oct 1, 2017, 00:00

  • National Survey Of Medication Safety Practice At Ministry Of Health Hospitals During Mass Gathering (Hajj-2016) In Saudi Arabia

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Ferric Carboxymaltose (FCM) in the Treatment of Iron Deficiency Anemia in Patients with Inflammatory Bowel Disease (IBD)

    Oct 1, 2017, 00:00

  • Embedding Randomized Controlled Trials into Medical Practice

    Oct 1, 2017, 00:00

  • Economic Evaluation of the Change from An Opportunistic Cervical Screening Program to an Organized Screening in Catalonia, Spain

    Oct 1, 2017, 00:00

  • Transsexual’s Sex Reassigment Process In Brazilian National Health System- Where Are We?

    Oct 1, 2017, 00:00

  • Real-World Evaluation Of Physician Attitudes Towards The Prescription Of Androgen Deprivation Therapy For Patients With Prostate Cancer

    Oct 1, 2017, 00:00

  • Modelling The Societal Impact Of Alirocumab In Patients With Severe Hypercholesterolemia Treated With Apheresis In Germany

    Oct 1, 2017, 00:00

  • Skin Pain In Psoriasis

    Oct 1, 2017, 00:00

  • Risk-Stratified Breast Cancer Screening and Non-Adherence in Germany

    Oct 1, 2017, 00:00

  • French People With MS And Their Caregivers Have To Financially Support Direct Non-Medical Costs Linked To Their Disease

    Oct 1, 2017, 00:00

  • Delaying Second Line Diabetes Treatment Onset In Patients Uncontrolled With Metformin Xr In Saudi Arabia- Cost-Effectiveness Analysis

    Oct 1, 2017, 00:00

  • Cost Study Of Immune Thrombocytopenia (ITP) Management From The French Hospital Perspective

    Oct 1, 2017, 00:00

  • Achieving Key Objectives In Rare Diseases Healthcare Policy In Spain- Contribution From A Dravet Syndrome Working Group

    Oct 1, 2017, 00:00

  • A Path Analysis of Effects of Patients’ Underlying Conditions, Treatment Satisfaction And Adherence on Quality of Life Among Korea Glaucoma Patients- Results From Korea Glaucoma Outcomes Research

    Oct 1, 2017, 00:00

  • Economic Evaluation And Cost-Effectiveness Threshold In Practice Of Decision-Making On Orphan Drug Reimbursement In Poland

    Oct 1, 2017, 00:00

  • A Robust, Reproducible Method For Evaluating The Suitability of Disparate Observational Databases for Pooled Analysis, Using The Omop Common Data Model

    Oct 1, 2017, 00:00

  • The Budget Impact Of Introducing A PD-L1 Assay To Select Patients With Metastatic Nsclc Who Are Potential Candidates For Treatment With Immune Checkpoint Inhibitors

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Trifluridine/Tipiracil for The Treatment of Metastatic Colorectal Cancer in Portugal

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis Of A Point-Of-Care Test For Renal Function Measurement In Community Pharmacies In The Netherlands To Prevent Antibiotic-Related Hospitalizations

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Nivolumab (NIVO) Combined with Ipilimumab (IPI) Compared with Nivo and Ipi Monotherapies in The First-Line Treatment of Advanced Melanoma in The United States- Analysis Using 28-Month Overall Survival (OS) Data from Ch ...

    Oct 1, 2017, 00:00

  • Comprehensive Knowledge and Uptake of Cervical Cancer Screening is Low Among Women Living with HIV/AIDS in Northwest Ethiopia

    Oct 1, 2017, 00:00

  • Direct Medical Costs In The Year Of Mortality For Patients With Diabetes- A Population-Based Patient-Level Analysis

    Oct 1, 2017, 00:00

  • Comparison of Secukinumab Vs Infliximab in a Cost Per Responder Analysis Based on a Matching-Adjusted Indirect Comparison of Efficacy Data for the Treatment of Psoriatic Arthrisis at 48 Weeks from a Moroccan Perspective

    Oct 1, 2017, 00:00

  • Comparing The Healthcare Cost Utilization Of Paediatric Patients With Haemophilia A With And Without Inhibitors Treated At Instituto De Seguridad Social Del Estado De Mexico Y Municipios

    Oct 1, 2017, 00:00

  • Cost Minimization Analysis and Budget Impact Model of Treatment of Chronic Hepatitis C Virus with Grazoprevir (Gzr, Mk - 5172 / Elbasvir (Ebr, Mk - 8742) in Patients with Genotypes 1 and 4 in Mexico

    Oct 1, 2017, 00:00

  • Systematic Literarture Review of Health-Related Quality of Life In Clostridium Difficile Infection

    Oct 1, 2017, 00:00

  • Ixekizumab Treatment Leads to Early Resolution of Bothersome Symptoms Versus Ustekinumab

    Oct 1, 2017, 00:00

  • Denosumab And Bisphosphonates Persistence, Compliance And Switch In Patients With Solid Tumors (ST) And Bone Metastases (BM)

    Oct 1, 2017, 00:00

  • Linguistic Validation Of Knowledge, Attitudes And Practice Of Zika Virus Disease Questionnaire Among The Malaysian General Public Using Rasch Model- A Cross-Sectional Study

    Oct 1, 2017, 00:00

  • The Impact Of Obesity And Deprivation On HRQOL Gains Following Hip And Knee Replacements

    Oct 1, 2017, 00:00

  • The Impact of Managed Entry Agreements on Drug Time to Market in Italy

    Oct 1, 2017, 00:00

  • Using Rasch Measurement To Quantify The Perceived Risks Associated With The Use Of Tobacco And Nicotine-Containing Products

    Oct 1, 2017, 00:00

  • A Business Case For Stroke Reduction Initiatives In Atrial Fibrillation- 3-Year Financial Projections For Three UK Regions

    Oct 1, 2017, 00:00

  • Utilization and Evaluation of Delphi Panels In German Amnog Assessments

    Oct 1, 2017, 00:00

  • Considerations for The Selection of Written Chinese Variants In The Process of Translating and Linguistically Validating Clinical Outcome Assessments (COAS)

    Oct 1, 2017, 00:00

  • Beyond Product Value - A Holistic Approach For Value Assessment

    Oct 1, 2017, 00:00

  • Assessment of Quality of Health Economic Studies In Non-Alcoholic Fatty Liver Disease

    Oct 1, 2017, 00:00

  • GLYCEMIC CONTROL IN PATIENTS WITH T2DM TREATED WITH SULFONYLUREAS ALONE OR IN COMBINATION WITH METFORMIN, ARGENTINA

    Oct 1, 2017, 00:00

  • Which Information Sources Should Be Used To Identify Studies for Systematic Reviews of Economic Evaluations In Healthcare?

    Oct 1, 2017, 00:00

  • Factors Influencing Innovative Drug Reimbursement In Poland

    Oct 1, 2017, 00:00

  • Development of The Oiqol-A- A Health-Related Quality of Life Measure For Adults With Osteogenisis Imperfecta

    Oct 1, 2017, 00:00

  • Cognitive Interviewing During Linguistic Validation Of Clinical Outcomes Assessments (COAS)- In-Person Or Video Chat – An Analysis Of Respondent Preference

    Oct 1, 2017, 00:00

  • Determinantes Do Atraso Escolar E DA Obesidade NOS Adolescentes Brasileiros (2012 E 2015)

    Oct 1, 2017, 00:00

  • Understanding Patients’ Ability to Function in Order to Inform Clinical Benefit in Oncology Studies

    Oct 1, 2017, 00:00

  • Estimating The Impact of Strategies For Cervical Cancer Prevention And Control In Indonesia Using Markov Model

    Oct 1, 2017, 00:00

  • Real World Treatment Patterns And Resource Use For Advanced Non-Small Cell Lung Cancer In Brazilian Private Institutions

    Oct 1, 2017, 00:00

  • Avoiding A Market For Lemons With Pharmaceuticals- How Risk-Sharing Mechanisms Can Improve Allocation

    Oct 1, 2017, 00:00

  • Comparing The Methods Of Incorporating The Health Related Quality Of Life Of Advanced Cancer Patients In Economic Models

    Oct 1, 2017, 00:00

  • Analysis of Warfarin Usage and INR Control in Atrial Fibrillation- A Retrospective Study

    Oct 1, 2017, 00:00

  • 20th Euro - FDS Financial Disclosure Statements

    Oct 1, 2017, 00:00

  • Economic Evaluation Of Cerebral Oximetry Monitoring In Carotid Endarterectomy- The Emocar Randomized Controlled Trial (May 2011 - April 2016)

    Oct 1, 2017, 00:00

  • Incontinence Control System (Interstim®) for the Fecal Incontinence Treatment at Healthcare Public Sector in Mexico

    Oct 1, 2017, 00:00

  • The Influence Of Age On Patient Attitudes And Acceptability Towards Using Their Own Mobile Device To Record Patient-Reported Outcomes Data In Clinical Trials

    Oct 1, 2017, 00:00

  • Infection Prevention In Heart Surgery In Germany- An Economic Analysis

    Oct 1, 2017, 00:00

  • The Cost Effectiveness of Oxycodone In Patients Who Do Not Respond To Morphine From The Brazilian Public Health System Perspective

    Oct 1, 2017, 00:00

  • PROS In Oncology HTA Decisions, Do They Matter?

    Oct 1, 2017, 00:00

  • Resource Use, Health Care Costs And Burden Of Disease In Patients With Polycythemia Vera In Finland- Evaluation Based On Leukocyte Counts Using Finnish Real World Data From Auria Biobank

    Oct 1, 2017, 00:00

  • Pharmacological Adherence to Clinical Guidelines in Acute Coronary Syndrome in Hospitals

    Oct 1, 2017, 00:00

  • Pricing Regulation In Greece - Analyzing The Price Bulletin Of December 2016

    Oct 1, 2017, 00:00

  • Cost-Per-Responder of Fixed Combination Calcipotriol + Betamethasone Dipropionate Aerosol Foam Vs Ointment In Patients With Psoriasis Vulgaris In The UK

    Oct 1, 2017, 00:00

  • How Will Payers Manage the Cost of New, Advanced Biologic and Oncologic Agents as Therapy Areas Become Crowded with Drugs with Similar Mechanisms of Action?

    Oct 1, 2017, 00:00

  • Budget Impact Analysis for Daclizumab Beta In Relapsing Remitting Multiple Sclerosis In Italy

    Oct 1, 2017, 00:00

  • Estudo De Custos Da Leishmaniose Visceral No Brasil

    Oct 1, 2017, 00:00

  • Potential Mortality Reduction with Optimal Usage of Sacubitril/Valsartan Therapy for the Treatment of Heart Failure in Chile

    Oct 1, 2017, 00:00

  • Cambios En La Calidad De Vida Relacionada Con La Salud De Pacientes Sometidos A Preparación Intestinal

    Oct 1, 2017, 00:00

  • Societal Preferences For Funding Orphan Drugs In The UK- A Person Trade Off Study

    Oct 1, 2017, 00:00

  • Burden of High Disease Activity in Systemic Lupus Erythematosus (SLE)- Results of A Targeted Literature Review

    Oct 1, 2017, 00:00

  • Conversion of a French Electronic Medical Record (Emr) Database into the Observational Medical Outcomes Partnership Common Data Model

    Oct 1, 2017, 00:00

  • Psychotropic Drug Use in Non Psychiatric Wards- Indian Scenario

    Oct 1, 2017, 00:00

  • Estudio De Costo Efectividad Del Factor De Coagulación Recombinante VIII Unido A Proteina Fc Para El Tratamiento De La Hemofilia A En Chile

    Oct 1, 2017, 00:00

  • Diabetes Mellitus Self-Management Interventions in Latino Adults in the United States - The Role of Pharmacists

    Oct 1, 2017, 00:00

  • The Analysis Of Final And Surrogate Effectiveness Criteria Used In Health Economic Studies Of Drugs Submitted Into The Reimbursement In Russia In 2016

    Oct 1, 2017, 00:00

  • Early Access To Medicines Pathways – Results Of A Global Survey

    Oct 1, 2017, 00:00

  • Economic Effectiveness Of The Attune® Knee System - Analysis Of Real World Hospital Length Of Stay And Incidence Of Early Complications

    Oct 1, 2017, 00:00

  • Effectiveness of The Peripherally Inserted Central Venous Catheter in Adult and Pediatric Patients

    Oct 1, 2017, 00:00

  • EVidence Synthesis For Health Technology Assessment With Limited Studies

    Oct 1, 2017, 00:00

  • An Evaluation of the Utilisation and Expenditure on Dual Antiplatelet Therapy (DAPT) in Ireland

    Oct 1, 2017, 00:00

  • Body Piercings- Epidemiological Study on a Representative Sample of 5,000 French Subjects

    Oct 1, 2017, 00:00

  • Knowledge And Attitudes About Ebola Virus Among Community Residents In The US- A Cross-Sectional Study

    Oct 1, 2017, 00:00

  • Family Caregiving in Dementia and its Impact on Quality of Life and Economic Burden in Japan – Web-Based Survey

    Oct 1, 2017, 00:00

  • The Impact of Treatment-Free Remission of Tasigna® for Cml Patients in China – A Cost Effectiveness Analysis

    Oct 1, 2017, 00:00

  • Predicting Dengue Fever Outbursts In Brazil- An Empirical Model Based On Climatic Parameters

    Oct 1, 2017, 00:00

  • An Introductive Analysis of the Timeframe from European Drugs Approval to the Sicilian Hospital Formulary Inclusion

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Tacrolimus As Primary Immunosuppression For Lung Transplant Recipients In The Czech Republic

    Oct 1, 2017, 00:00

  • Tasas De Hospitalización De Los Pacientes Con Defectos De La Coagulación (Demanda Y Profilaxis) EN UNA Aseguradora Colombiana

    Oct 1, 2017, 00:00

  • Health Economic Evaluations in Inflammatory Bowel Disease in Brazil- A Systematic Review

    Oct 1, 2017, 00:00

  • Effectiveness Of Osteoporosis Drugs In Preventing Secondary Hip Fractures In Women On Dialysis

    Oct 1, 2017, 00:00

  • Cost-Savings Due to The Withdrawing of Biological Therapy for Treatment of Rheumathoid Artritis in A Specialized Center in Colombia

    Oct 1, 2017, 00:00

  • Budget Impact Analysis Of Incisional Hernia Repairs Considering Poly-4-Hydroxybutyrate Resorbable Meshes

    Oct 1, 2017, 00:00

  • A Retrospective Analysis Of Surgery Time For Echo PS™ Positioning System With Ventralight™ St VS Flat Mesh By Size In Outpatient Hospital Laparoscopic Hernia Repair Procedures

    Oct 1, 2017, 00:00

  • Efficacy And Safety Outcomes of Recanalization Procedures In Patients with Acute Symptomatic Pulmonary Embolism- Systematic Review And Network Meta-Analysis

    Oct 1, 2017, 00:00

  • Comparing The Effect of Progressive Relaxation And Perineal Strenghtening Interval Exercises Among Women With Primaer Dysmenorrhoea To Reduce Menstrual Cramps

    Oct 1, 2017, 00:00

  • Secukinumab As A More Efficient Alternative For The Treatment of Ankylosing Spondylitis- A Cost Per Responder Analysis Versus Adalimumab And Golimumab From A Peruvian Perspective For Private And Public Health Schemes

    Oct 1, 2017, 00:00

  • The FDA Approval of Eteplirsen – Necessary Flexibility or a Worrying Precedent?

    Oct 1, 2017, 00:00

  • Cost Effectiveness Analysis of Exemestane Versus Capecitabine Monotherapy for Patients with Hormone Receptor–Positive and Her2-Negative, Metastatic Breast Cancer from National Cancer Institute Prespective in Egypt

    Oct 1, 2017, 00:00

  • Reviewing The Effectiveness of Uk Drug Horizon Scanning Efforts The Production of Nice Commentary Along Therapeutic Specialties

    Oct 1, 2017, 00:00

  • Quality Of Life In Patients With Knee Arthritis In Slovak Republic

    Oct 1, 2017, 00:00

  • Budget Impact Analysis of Oral Glycopyrronium Bromide (Sialanar™) For The Symptomatic Treatment of Severe Sialorrhoea (DROOLING) In The UK Setting

    Oct 1, 2017, 00:00

  • A Trend Towards Increased Use Of Patient Access Schemes (PAS) To Gain UK Reimbursement

    Oct 1, 2017, 00:00

  • The Cost-Effectiveness Of Tavi In Inoperable And High Risk Patients In France

    Oct 1, 2017, 00:00

  • Drugprice Developments After Patent Expiry

    Oct 1, 2017, 00:00

  • The Use of The Eortc Item Library To Supplement Eortc Quality of Life Instruments

    Oct 1, 2017, 00:00

  • Real-World Patient Characteristics And Patterns Of Care Among Metastatic Urothelial, Head And Neck, Non-Small Cell Lung Cancer Patients Using A German Sickness Fund Claims Database

    Oct 1, 2017, 00:00

  • Optimal Interval of Endoscopic Screening Based on Stage Distribution of Detected Gastric Cancer

    Oct 1, 2017, 00:00

  • The Cost-Effectiveness of Pegaspargase for First-Line Treatment of Acute Lymphoblastic Leukaemia- A Cost-Utility Analysis

    Oct 1, 2017, 00:00

  • Fractional Polynomial Modelling In Network Meta-Analyses Of Cancer Immunotherapies In Advanced Non-Small Cell Lung Cancer (NSCLC)

    Oct 1, 2017, 00:00

  • Real-World Resource Use And Costs Of Treating Controlled And Uncontrolled Carcinoid Syndrome- A Retrospective Swedish Study

    Oct 1, 2017, 00:00

  • Heart Failure Management- Impact Of A New Health-Care Organisation On Readmissions And Costs

    Oct 1, 2017, 00:00

  • The Economic Impact of Optimizing Therapy In ‘Hard-To-Treat’ and ‘Harder-To-Treat’ Hypothyroid Patients by Changing the Levothyroxine Formulation from Tablets to Gel Caps

    Oct 1, 2017, 00:00

  • The Relationship Of Predicted Benefits In Life Expectancy And Quality Adjusted Life Expectancy For Improved Glucose Control In Type 2 Diabetes Simulation Modeling

    Oct 1, 2017, 00:00

  • Analysis of The Individual Economic Burden (BORNE-COST BY THE PATIENTS) In Adult Patients With Atopic Dermatitis

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Thresholds- Review of Methods

    Oct 1, 2017, 00:00

  • Epidemiology of Locally Advanced or Metastatic Urothelial Cancer In The US, Europe And Japan

    Oct 1, 2017, 00:00

  • Cost-Minimization Analyses of Biological Therapies in the Treatment of Rheumatoid Arthritis from the Egyptian Healthcare System Perspective

    Oct 1, 2017, 00:00

  • IMPACT OF WEIGHT LOSS (WL) ON HEALTH-RELATED QUALITY OF LIFE (HRQOL) AMONG LATIN AMERICAN (LA) SUBJECTS WITH TYPE 2 DIABETES MELLITUS (T2DM) IN PHASE 3 STUDIES OF CANAGLIFLOZIN (CANA)

    Oct 1, 2017, 00:00

  • Possible Mistakes During Blood Pressure Measuring- Inappropriate Posture

    Oct 1, 2017, 00:00

  • An Evaluation Of The Budget Impact Of The New 20% Subcutaneous Immunoglobulin (IG20GLY) For The Management Of Primary Immunodeficiency Diseases In Switzerland

    Oct 1, 2017, 00:00

  • Predictors of Early Discontinuation of Interferon-Free Direct Antiviral Agents in Patients With HCV and Advanced Fibrosis- Results of A Real-Life Cohort

    Oct 1, 2017, 00:00

  • Cost-Utility Analysis Of Rosuvastatin Compared To Atorvastatin In Primary Prevention Of Myocardial Infarction Among HIV-Positive Patients On Haart In Uganda

    Oct 1, 2017, 00:00

  • Identification of Generic Cancer Medicines That Have Undergone Momentous Price Rises in The Nhs in England

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Ribociclib Plus Letrozole Versus Palbociclib Plus Letrozole for Postmenopausal Women with Hormone Receptor-Positive (HR+), Human Epidermal Growth Factor Receptor 2-Negative (HER2–) Advanced/Metastatic Breast Cancer fro ...

    Oct 1, 2017, 00:00

  • TRENDS AND PREDICTIVE FACTORS OF HRQOL IN TRAUMA PATIENTS. - A PROSPECTIVE COHORT STUDY

    Oct 1, 2017, 00:00

  • The Traditional Ethnobotanical Knowledge Applied in Parasitology in the Andean Cordillera of Ecuador

    Oct 1, 2017, 00:00

  • Conventional and Biological Therapy in Patients with Rheumatoid Arthritis. A Cost Analysis in Colombia

    Oct 1, 2017, 00:00

  • Heterogeneous Preferences in the Adjunct Drug Treatment of Severe Hypercholesterolemia- A Latent-Class Analysis

    Oct 1, 2017, 00:00

  • Access to Orphan Drugs (ODS) in Spain Compared with EU4 Countries- Inequity and Lack of Price Transparency Across Europe

    Oct 1, 2017, 00:00

  • Early Economic Evaluation of The New Atypical Antipsychotic

    Oct 1, 2017, 00:00

  • Number of Cases Based on The Most Commonly Funded Diseases In Home Special Care In Hungary, 2013

    Oct 1, 2017, 00:00

  • Forecasting The Potential Public Health Impact of Herpes Zoster Vaccination In Italy

    Oct 1, 2017, 00:00

  • Examining Health Care Utilization and Costs Among Atherosclerosis Patients in the US Veteran Health Administration Population

    Oct 1, 2017, 00:00

  • Cost Effectiveness Analysis of Hemostatic Matrix Pads VS Standard of Care In Cardiac Surgery (Italian Hospital Perspective)

    Oct 1, 2017, 00:00

  • The Health-Related Quality Of Life (HRQOL) Associated With Ostomy Appliances And Features

    Oct 1, 2017, 00:00

  • Review Of Real-World Evidence To Assess The Burden Of Illness Of Mantle Cell Lymphoma

    Oct 1, 2017, 00:00

  • Secukinumab Vs Adalimumab for the Treatment of Psoriasic Arthritis- a Cost Per Responder Analysis at 48 Weeks from a Peruvian Perspective for Public and Private Health Schemes

    Oct 1, 2017, 00:00

  • The Modelled Effectiveness of Ruxolitinib on Survival in Polycythemia Patients with Hydroxyurea Resistance/Intolerance in Turkey

    Oct 1, 2017, 00:00

  • Impact of Spironolactone on Das-28 in Naive Rheumatoid Arthritis Patients

    Oct 1, 2017, 00:00

  • Treatment Patterns of Chronic Heart Failure (CHF) In Brazil

    Oct 1, 2017, 00:00

  • Difference Between Annual National Health Statistics And 1-Complete-Year Medical Use In Cost-Estimation

    Oct 1, 2017, 00:00

  • Municipal Health Conferences In The State Of Baden-Wuerttemberg, Germany – Ready For Initiating And Steering Primary Health Care Provisions At Community Level?

    Oct 1, 2017, 00:00

  • Comparison of Catheter Ablation Versus Medical Treatment for Paroxysmal Atrial Fibrillation- Healthcare Utilization and Costs Analysis (Preliminary Results)

    Oct 1, 2017, 00:00

  • The Patient-Reported Apnea Questionnaire (PRAQ)- A Prom Optimized For Use On Both Individual Patient And Aggregate Level

    Oct 1, 2017, 00:00

  • Mobile Cardiac Monitorization Is A Cost-Effective Tool For The Diagnosis And Management Of Atrial Fibrillation Compared To Holter- A Cost Effectiveness Study In Turkey

    Oct 1, 2017, 00:00

  • Prescribing Pattern Along With Pharmacoeconomic Evaluation In Primary Health Care Facilities Nepal

    Oct 1, 2017, 00:00

  • New Drugs Approval In Italy- Analysis Of The Applied Negotiation Conditions 2015-2017

    Oct 1, 2017, 00:00

  • The Implications of Brexit on The UK Nhs and The UK Pharmaceutical Industry

    Oct 1, 2017, 00:00

  • The UK's Binge Drinking Culture- Losing More Than Just Our Dignity?

    Oct 1, 2017, 00:00

  • Difficulties In Vaccine Introduction In A Large-Area Country- Meningococcal Vaccination In Russia

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Brivaracetam As Adjunctive Therapy for Partial-Onset Epilepsy In The Finnish Setting

    Oct 1, 2017, 00:00

  • Budget Impact Analysis of Paliperidone Palmitate 3-Monthly for The Treatment of Schizophrenia In Italy

    Oct 1, 2017, 00:00

  • Evaluation And Development of Habitual Posture And Posture Deemed Correct With Back School Program Among Primary School Children

    Oct 1, 2017, 00:00

  • Unmet Healthcare Needs Due To Financial Reasons In Times Of Austerity

    Oct 1, 2017, 00:00

  • Modelling Cardiovascular Outcomes In Type 2 Diabetes In The ERA Of Cardiovascular Outcomes Trials

    Oct 1, 2017, 00:00

  • Adapting Pharmacoeconomics To Shape Efficient Health Systems En Route To Uhc - A Conceptual Framework

    Oct 1, 2017, 00:00

  • Developing A Conceptual Modelling Framework For Economic Evaluation

    Oct 1, 2017, 00:00

  • The Association Between Multimorbidity, Socioeconomic Factors, And Multimorbidity-Related Excess Healthcare Use - Results From The 2014 National Health Interview Survey

    Oct 1, 2017, 00:00

  • Patient Characteristics, Skeletal Related Events (SRE) And Renal Impairment (RI) In Patients With Multiple Myeloma (MM)- A Patient Chart Audit In EU5

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Afatinib Versus Erlotinib for The Treatment of Squamous Non-Small Cell Lung Cancer in France After A First-Line Platinium Based Therapy

    Oct 1, 2017, 00:00

  • Real-World Evidence of Direct-Acting Antivirals Persistence on Planned Hepatitis C Treatment

    Oct 1, 2017, 00:00

  • Cost Consequence Analysis of Immune-Enhancing Nutritional Formula in Patients with Digestive Cancer Surgery

    Oct 1, 2017, 00:00

  • Análise De Custo Efetividade Da Toxina Onabotulínica A No Tratamento Preventivo Da Migrânea Crônica

    Oct 1, 2017, 00:00

  • The Budget Impact of Introducing Demineralised Bone Matrix Combined with Local Bone to Replace Currently Available Treatments for Lumbar Spinal Fusion Procedures in Spain

    Oct 1, 2017, 00:00

  • Cost Consequence Analysis Of Different Gene Mutation Testing Modalities For Braf V600E Mutation In Advanced Non-Small Cell Lung Cancer Using A Decision Analytic Model

    Oct 1, 2017, 00:00

  • Budget Impact Analysis of The Use of Daclatasvir + Asunaprevir In The Treatment of Patients With Chronic Hepatitis C in Peru

    Oct 1, 2017, 00:00

  • Early Response To Certolizumab Pegol In Rheumatoid Arthritis Predicts Outcome- Data From A Prospective Observational Study

    Oct 1, 2017, 00:00

  • Impact of Low Adherence On Cost-Effectiveness Of The Biological Treatment of Psoriasis (PSO) And Psoriatic Arthritis (PSA) In Slovenia

    Oct 1, 2017, 00:00

  • A Model For Alzheimer’s Disease In The Prevention Setting

    Oct 1, 2017, 00:00

  • A Systematic Review of The Health-Related Quality of Life and Costs in Diffuse Large B-Cell Lymphoma

    Oct 1, 2017, 00:00

  • The Cost of Tiotropium 5MCG + Olodaterol 5MCG In The Management Of Copd In Greece

    Oct 1, 2017, 00:00

  • I-O Optimise- Developing A Unique Multinational Real-World Evidence-Based Research Platform In Oncology

    Oct 1, 2017, 00:00

  • The Effect of Perceived Financial Burden of Prescription Co-Payments on Medication Adherence

    Oct 1, 2017, 00:00

  • Modelling The Burden Of Cardiovascular Disease In Mexico And The Impact Of Reducing Modifiable Risk Factors

    Oct 1, 2017, 00:00

  • Real World Treatment Patterns of PCSK9 Inhibitors Among Patients with Dyslipidemia in Germany, Spain, and United Kingdom

    Oct 1, 2017, 00:00

  • Assessing Methodologies For Health State Utilities In Paediatric Indications For Cost-Utility Analyses- Review Of Nice Technology Appraisals For Paediatric Indications

    Oct 1, 2017, 00:00

  • Patient Characteristics And Bleeding Events In Non-Valvular Atrial Fibrillation Patients Treated With Apixaban or Vitamin K Antagonists- Real-World Evidence From Italian Administrative Databases

    Oct 1, 2017, 00:00

  • Drug Utilization and Pharmacological Costs of Intravitreal Injected Antivegfs in Maculopathies in San Raffaele Hospital

    Oct 1, 2017, 00:00

  • Selecting Software Packages For Conducting Cost-Effectiveness Modelling In Health Care

    Oct 1, 2017, 00:00

  • Cost Effectiveness Analysis of Sorafenib Versus Best Supportive Care in Patients with Advanced Hepatocellular Carcinoma from Health Care System Perspective in Egypt

    Oct 1, 2017, 00:00

  • The Multicriteria Decision Analysis Of Using Tetrabenazine For Patients With Hungtington’s Disease In Russia

    Oct 1, 2017, 00:00

  • Systematic Literature Review Of Economic Evaluations And Healthcare Resource Utilisation Studies In The Treatment Of Clostridium Difficile Infection

    Oct 1, 2017, 00:00

  • Health-Related Quality Of Life And Rates Of Emergency Room Visits And Hospitalization In Patients With Al Amyloidosis- A Prospective Analysis

    Oct 1, 2017, 00:00

  • Assessment of Marketed and In-Development Products for Alzheimer’s Disease- What are the Strategic Value Drivers?

    Oct 1, 2017, 00:00

  • Spirometry of Lung Function Evaluation in Stone Crushing Workers Quetta, Pakistan

    Oct 1, 2017, 00:00

  • Qualitative Evaluation of Healthcare Provider Trust (And Mistrust) Among Patients with Symptomatic Peripheral Artery Disease

    Oct 1, 2017, 00:00

  • Treatment for Cervix Uteri Cancer- Cost-Effectiveness Analysis in A Developing Country Context

    Oct 1, 2017, 00:00

  • Cost Effectiveness of Pcv13 Vs Ppsv23 For The Immunization of Adults Over 65 Years with Low or Moderate Risk of Pneumococcal Infection

    Oct 1, 2017, 00:00

  • Port Catheter Versus Peripherally Inserted Central Catheter For Adjuvant Chemotherapy In Breast Cancer- A Cost-Effectiveness Analysis

    Oct 1, 2017, 00:00

  • Why Do ‘True’ Orphan Medicines Have Such A Low Acceptance Rate When Assessed By The SMC?

    Oct 1, 2017, 00:00

  • Value Of Information Analysis Using Generalized Additive Model Regression- A Case Study In Heart Failure Disease Management

    Oct 1, 2017, 00:00

  • O Indicative Budget Impact Of Posaconazole Versus Itraconazole In Invasive Fungal Infection Prophylaxis In Adult Patients With Aml/Mds

    Oct 1, 2017, 00:00

  • Closing The Evidence Gap For Orphan Drugs- Do German Regulatory Requirements Give Incentives For High Level Evidence Generation?

    Oct 1, 2017, 00:00

  • Economic Burden Of Household For Treating Severe Pneumonia Among Under Five Children In Bangladesh

    Oct 1, 2017, 00:00

  • Application Of Balancing Techniques In Studies Utilizing German Administrative Claims Data

    Oct 1, 2017, 00:00

  • The Effectiveness and Cost-Effectiveness of Tobacco Control Mass Media Campaigns In Scotland

    Oct 1, 2017, 00:00

  • Developing New Practice Model To Ensure Better Medication Concordance

    Oct 1, 2017, 00:00

  • Stigmatisation Level Towards Mental Illness Patients Among Malaysian Urban and Rural Communities

    Oct 1, 2017, 00:00

  • Poor Outcomes Associated with Antithrombotic Potential Undertreatment in Patients with Atrial Fibrillation- A Retrospective Cohort Study

    Oct 1, 2017, 00:00

  • A Dynamic Decision Analysis Process For Evaluating Pandemic Influenza Intervention Strategies

    Oct 1, 2017, 00:00

  • The Introduction Of A Threshold For The Icer And The Implications For Reimbursement Of Drugs In The Dutch Healthcare System

    Oct 1, 2017, 00:00

  • Generics Policies- A Systematic Review Of Their Effectiveness

    Oct 1, 2017, 00:00

  • Budget Impact Analysis of Same And Mixed Budesonide And Formoterol Inhalers In The Treatment of Asthma In Russian Federation

    Oct 1, 2017, 00:00

  • Osteopathic Manipulative Therapy In Patients With Headache- Systematic Literature Review

    Oct 1, 2017, 00:00

  • Effectiveness Of Lacosamide For The Treatment Of Non-Controlled Focal Epilepsy

    Oct 1, 2017, 00:00

  • Pharmacoeconomic Analisys of Trastuzumab Emtanzine in Patients with Metastatic Breast Cancer and Central Nervous System Metastases

    Oct 1, 2017, 00:00

  • Requirements For A Novel Inhaled Combination To Improve Management Of Pseudamonas Aeruginosa Infections In Cystic Fibrosis Patients - A Payer Perspective

    Oct 1, 2017, 00:00

  • Real-World Multiple Myeloma Treatment Pattern In Morocco- Evidence From Patient Chart Audit

    Oct 1, 2017, 00:00

  • Combined Use of Isoniazid and Rifapentine in The Treatment of Latent Tuberculosis- A Budget Impact Analysis

    Oct 1, 2017, 00:00

  • Disease Burden Mapping In Rare Diseases- An Example of Hypophosphatasia

    Oct 1, 2017, 00:00

  • Adequately Reflecting The Clinical Benefits In Rare Disease Economic Modeling Using Sma Type I As A Casestudy

    Oct 1, 2017, 00:00

  • Potential Funding Sources For Breakthrough Therapies

    Oct 1, 2017, 00:00

  • Exploring The Association Between Risk Of Bleeding And Comorbid Conditions For Patients With Warfarin Treatment

    Oct 1, 2017, 00:00

  • Determinantes De La Calidad De Vida Relacionada Con La Salud En Pacientes Con VIH/SIDA EN UNA Aseguradora EN Salud EN Colombia

    Oct 1, 2017, 00:00

  • Economic Burden on families of Children Receiving inpatient Care

    Oct 1, 2017, 00:00

  • A Budget Impact Analysis of Fidaxomicin Versus Vancomycin and Metronidazole for the Treatment of Clostridium Difficile

    Oct 1, 2017, 00:00

  • Mapping From The Bdi-Ii To The EQ-5D-5L Questionnaire In Patients With Major Depression Disorder

    Oct 1, 2017, 00:00

  • NATIONAL POLICY ON HEALTH TECHNOLOGY MANAGEMENT- A CASE STUDY OF THE NATIONAL COMMITTEE FOR TECHNOLOGY INCORPORATION, BRAZIL (CONITEC)

    Oct 1, 2017, 00:00

  • Reduction of LDL-C Levels is Most Important - Patient Preferences for Drug Treatment Adjunct to LDL-C Apheresis in Severe Hypercholesterolemia

    Oct 1, 2017, 00:00

  • Can Early Access Support Continued Access? The Relationship Between Eams And Nice

    Oct 1, 2017, 00:00

  • Growth Hormone Pharmacoeconomics and Prescription Data for Children Outpatients in a Regional General Hospital

    Oct 1, 2017, 00:00

  • A Systematic Literature Review Of The Measurement Properties Of Generic Utility Instruments In East And Southeast Asia

    Oct 1, 2017, 00:00

  • Regional Distribution of The Most Common SPA Services In Hungary In 2014

    Oct 1, 2017, 00:00

  • Incidence of Non-Small-Cell Lung Cancer And Burden of Egfr Mutations- A 10-Year Global Forecast

    Oct 1, 2017, 00:00

  • The Impact Of Systemic Juvenile Idiopathic Arthritis (SJIA) On A Caregiver’s Productivity And The Child’s Schooling

    Oct 1, 2017, 00:00

  • Consumer Comments in Health Technology Assessment in Australia- How Common and Influential Are They?

    Oct 1, 2017, 00:00

  • Trends In Opioid Prescribing In Primary Care Patients With Knee Osteoarthritis- A Population Based Observational Study

    Oct 1, 2017, 00:00

  • Evaluation of the Cost Saving Potential of Introducing an Etanercept Biosimilar (SB4) for the Treatment of Approved Etanercept Indications in the Republic of Ireland

    Oct 1, 2017, 00:00

  • Economic Evaluation Of Anaferon® In The Treatment Of Acute Respiratory Infections In Mexico

    Oct 1, 2017, 00:00

  • Trend Analysis of Listing And Budget Impact For Orphan Drugs In Korea

    Oct 1, 2017, 00:00

  • Secukinumab Shows Higher Symptomatic Improvement and Lower Cost Per Response vs. Adalimumab After One Year Treatment of Active Ankylosing Spondylitis- A Cost Per Responder Analysis from A Chilean Perspective

    Oct 1, 2017, 00:00

  • Rasch Measurement Analysis Of The Lower Extremity Functional Scale For Foot And Ankle Patients

    Oct 1, 2017, 00:00

  • Direct Costs And Healthcare Resource Use Associated With Patients With Hypercholesterolaemia And Established Cardiovascular Disease In Spain

    Oct 1, 2017, 00:00

  • Burden Of Illness Of Deep Vein Thrombosis In Europe – Mortality And Health Related Quality Of Life

    Oct 1, 2017, 00:00

  • Lessons Learned with Managed Entry Agreements in Portugal

    Oct 1, 2017, 00:00

  • Assessing Racial Disparity In Palliative Care Consultation And The Impact Of Palliative Care Consultation On Hospi A Multi-Hospital Analysis

    Oct 1, 2017, 00:00

  • Predicting EQ-5D Utility Index Scores for Gastric Cancer Patients in Japan- A Preliminary Model

    Oct 1, 2017, 00:00

  • The Effectiveness And Cost-Effectiveness Of Different Methods Of Recruiting Patients To A Pain Study

    Oct 1, 2017, 00:00

  • Validation of a Screening Tool (ICUSI QUESTIONNAIRE) for AF Patients Receiving Vitaminin K Antagonist Therapy

    Oct 1, 2017, 00:00

  • Orphan Drugs In Fran Key Market Access Incentives

    Oct 1, 2017, 00:00

  • Evaluating Robotreviewer for Automated Risk of Bias Assessment in a Systematic Review- A Case Study

    Oct 1, 2017, 00:00

  • Engaging Patients In The Development and Validation of Patient-Reported Outcome (PRO) Measures As Partners, Not Just Participants

    Oct 1, 2017, 00:00

  • Assessing The Robustness Of Network Meta-Analysis Of Atypical Antipsychotics In The Presence Of Heterogeneity

    Oct 1, 2017, 00:00

  • Characteristics and cost burden of adverse drug reactions in a tertiary health care hospital in southern chile

    Oct 1, 2017, 00:00

  • Budget Impact Analysis of Dabrafenib and Trametinib Combination Therapy in The Treatment of Braf V600e-Mutant Advanced Non-Small Cell Lung Cancer in The United States

    Oct 1, 2017, 00:00

  • How Do Nice Evidence Review Groups Perceive Single Technology Appraisals Presenting Limited Evidence of Comparative Treatment Efficacy?

    Oct 1, 2017, 00:00

  • Pricing Regulation For Generics In Gree The Case Of Atorvastatin

    Oct 1, 2017, 00:00

  • Adapting The United States’ Antimicrobial Stewardship Programme Guidelines To Build An Economic Evaluation Framework For Chinese Hospitals

    Oct 1, 2017, 00:00

  • Inclusion Of Safety/ADR-Related Outcomes In Economic Evaluations For Seasonal Influenza Vaccines- A Review Of Available Studies

    Oct 1, 2017, 00:00

  • The Cost Effectiveness of Omalizumab For The Treatment of Severe Allergic Ashtma In Korea

    Oct 1, 2017, 00:00

  • Why Do People Participate In Health-Related Preference Studies? A Discrete-Choice Experiment

    Oct 1, 2017, 00:00

  • The Cost-Effectiveness of Daclizumab Beta Vs Fingolimod for The Treatment of Relapsing-Remitting Multiple Sclerosis Patients With Inadequate Response To Prior Treatment In Scotland

    Oct 1, 2017, 00:00

  • Model Types Submitted To Ni What Is Considered Appropriate By Evidence Review Groups?

    Oct 1, 2017, 00:00

  • Health Care Consumption And HRQOL In Severe Asthma In Sweden

    Oct 1, 2017, 00:00

  • Investigation Of Drug Therapy Problems In Type 2 Diabetes Outpatients With Comorbid Hypertension In A Tertiary Hospital In Southeast Nigeria

    Oct 1, 2017, 00:00

  • Delayed Biologic Switching Among Psoriatic Arthritis (Psa) Patients May Result in Poor Health-Related Quality of Life- Results From A Multi-National Survey Including Latin America

    Oct 1, 2017, 00:00

  • Persistence, Compliance And Bisphosphonate Switching In Patients With Multiple Myeloma (MM) In Germany

    Oct 1, 2017, 00:00

  • Mimicking Real Life Decision-Making in Health- Allowing Respondents Time-To-Think in a Discrete Choice Experiment

    Oct 1, 2017, 00:00

  • Clinical Characteristics and Outcome of The Influenza A (H1N1) Patients Admitted to the Tertiary Level Hospital, Peshawar

    Oct 1, 2017, 00:00

  • Cost-Utility Analysis of Biological Therapies In Psoriasis Using Real World Evidence

    Oct 1, 2017, 00:00

  • Predicting The Future Costs of Cancer Based on Register Data and Innovation Trends

    Oct 1, 2017, 00:00

  • Factors Associated With Sustained Smoking After Type 2 Diabetes Diagnosis In Korean Men

    Oct 1, 2017, 00:00

  • Does The Presence of An Orphan Drug Polcy Affect HTA Recommendations For Oncologic Orphan Drugs?

    Oct 1, 2017, 00:00

  • Cost-Minimization Analysis Of HPV 16/18 Genotyping Test Versus HPV Reflex Genotyping For Cervical Cancer Screening

    Oct 1, 2017, 00:00

  • Estimación De Costos De Los Servicios De Hemodiálisis Crónica Y Hemodiafiltración EN Argentina

    Oct 1, 2017, 00:00

  • Access To Medicines- Developing An Indicator To Assess The Impact of Public Policies

    Oct 1, 2017, 00:00

  • Cetuximab in the First-Line Treatment of Ras Wild-Type Metastatic Colorectal Cancer with Liver-Limited Disease

    Oct 1, 2017, 00:00

  • The Impact of Health Policy on The Pharmaceutical Supply Chain In France

    Oct 1, 2017, 00:00

  • The Cost Of Dialectic Behaviour Therapy (DBT) For People Diagnosed With Borderline Personality Disorder (BPD)- A Review of The Literature

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Ivabradine In The Treatment of Patients With Chronic Heart Failure In Iran

    Oct 1, 2017, 00:00

  • Characterization Of Low Density Lipoprotein (LDL) Levels In Patients Diagnosed With Cronic Kidney Disease In Colombian Population In The Year 2016

    Oct 1, 2017, 00:00

  • Cost Of Treatment-Related Adverse Events (TRAES) In Second-Line (2l) Advanced Hepatocellular Carcinoma (AHCC)- Match Adjusted Indirect Comparison (MAIC) Of Nivolumab And Regorafenib

    Oct 1, 2017, 00:00

  • One-Center Analysis of Cost Associated With Acromegaly Management In Poland

    Oct 1, 2017, 00:00

  • The Difference Between Regulatory And Market Access Decisions On Treatment Availability For New Drugs In Six Common Cancers Across Australia, Canada, And Europe

    Oct 1, 2017, 00:00

  • Single Distribution, Two-Part, and Two-Component Finite Mixture Models for Predicting Smoking-Related Indirect Costs In Us Working Adults

    Oct 1, 2017, 00:00

  • Secukinumab shows Higher Symptomatic improvement Versus Etanercept in Psoriatic Arthritis- Comparative Effectiveness Up To 24 Weeks Assessed by Matching-Adjusted Indirect Comparison

    Oct 1, 2017, 00:00

  • The Burden of Urothelial Carcinoma for the Brazilian Public Health System- A National Retrospective Analysis From 2013 TO 2016

    Oct 1, 2017, 00:00

  • A Retrospective Database Analysis of Treatment Pathways And Estimated Costs of Treatment In Metastatic Colorectal Carcinoma (MCRC) In Germany

    Oct 1, 2017, 00:00

  • Pharmacoepidemiology of Lateral Amiotrophic Sclerosis in the Republic of Belarus

    Oct 1, 2017, 00:00

  • Addressing Uncertainty In Wound Management Using A Modified Delphi Methodology

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Lidocaine Medicated Patch Compared with Pregabalin and Gabapentin for the Treatment of Postherpetic Neuralgia an Diabetic Polyneuropathy in Colombia

    Oct 1, 2017, 00:00

  • Factors Associated with an Adherence with Antiepileptic Drugs in Children Treated in Pediatric Practices in Germany

    Oct 1, 2017, 00:00

  • Tofacitinib in Adult Patients with Active Rheumatoid Arthritis- Budget Impact Analysis

    Oct 1, 2017, 00:00

  • Bleeding-Related Episodes (BRE) in Patients With Immune Thrombocytopenia (ITP) Receiving Eltrombopag (EPAG) or Romiplostim (ROMI)- Real World Evidence from 26 US Institutions

    Oct 1, 2017, 00:00

  • Calculating The Return On Investment For Ifn-Free DAAS- The Case Of Greece

    Oct 1, 2017, 00:00

  • Modeling Techniques for Fitting Healthcare Resource Use Costs Derived From Patient Reported Counts of Hospital, ER, And PCP Visits

    Oct 1, 2017, 00:00

  • Challenges In Demonstrating Disease-Modifying Effects- Evidence-Based Testing Of A Novel Statistical Approach In Alzheimer’s Disease

    Oct 1, 2017, 00:00

  • Management Of Healthcare Priorities By Single Natural Resource Driven Economies In Emerging Markets During Commodity Price Fluctuations

    Oct 1, 2017, 00:00

  • Incidence and Costs of Hypoglycemia In Diabetes Patients Initiated On Basal Insulin- A Population-Based Study

    Oct 1, 2017, 00:00

  • Economic Evaluation Of Neonatal Screening For Congenital Hypothyroidism

    Oct 1, 2017, 00:00

  • Clinical And Cost Impact of A Novel Non-Invasive Approach For The Treatment of Cervical Dysplasia From A US Payer Perspective

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Of High-Throughput, Non-Invasive Prenatal Testing For Fetal Rhesus D Status

    Oct 1, 2017, 00:00

  • Healthcare Resource Utilization And Costs For Total Hip Arthroplasty- Benchmarking The Anterior Approach In The Medicare Population

    Oct 1, 2017, 00:00

  • Developing and Piloting A Value Framework and a Tool to Inform the “Evidence-to-Decision Making” Process

    Oct 1, 2017, 00:00

  • Terms Requiring Multiple Translations Or A Descriptive Translation In The Target Language And Vice Versa

    Oct 1, 2017, 00:00

  • Α Systematic Review of Economic Evaluations of Biological Therapies for the Treatment of Ulcerative Colitis

    Oct 1, 2017, 00:00

  • Systematic Review of Observational Studies of Interferon-Free Treatments for Chronic Hepatitis C

    Oct 1, 2017, 00:00

  • The Evolution of Nice Medtech Innovation Briefings And Their Associated Technologies

    Oct 1, 2017, 00:00

  • Development And Psychometric Evaluation Of An Owner-Completed Measure Of Feline Health And Quality Of Life

    Oct 1, 2017, 00:00

  • The Potential Value Of Multiparametric Magnetic Resonance Imaging In Active Surveillance Of Men With Low-Risk Prostate Cancer- A Cost-Effectiveness Modeling Study

    Oct 1, 2017, 00:00

  • Impact of Comprehensive Genomic Profiling of Patients With First Line Non-Small Cell Lung Cancer In The UK

    Oct 1, 2017, 00:00

  • The Cost-Effectiveness of Sacubitril/Valsartan In The Treatment Of Chronic Heart Failure With Reduced Ejection Fraction In Turkey

    Oct 1, 2017, 00:00

  • Assessing The Utilization Of Diabetic Non-Small Cell Lung Cancer Patients Compared To Non-Small Cell Lung Cancer Patients

    Oct 1, 2017, 00:00

  • Specificities of Cancer Immunotherapy – Challenges From Market Access Perspective

    Oct 1, 2017, 00:00

  • Network Meta-Analysis In The Evaluation of Vaccines

    Oct 1, 2017, 00:00

  • USO De Los Índices De Shannon En La Evaluación Del Poder Discriminante Del EQ-5D Y EL EQ-5D-5L En UNA Muestra De Pacientes Con VIH/SIDA En Colombia

    Oct 1, 2017, 00:00

  • Do EU5 Countries with Favourable Healthcare Expenditure and Reimbursement Indicators Have Better Patient-Reported Access to Treatments for Rare Diseases?

    Oct 1, 2017, 00:00

  • Delayed Biologic Switching Among Ankylosing Spondylitis (As) Patients May Result in Poor Health- Related Quality of Life- Results From A Multi-National Survey Including Latin America

    Oct 1, 2017, 00:00

  • Trends In Oncology Appraisal Decisions- A Comparison Between The National Institute For Health And Care Excellence (NICE) And The Scottish Medicines Consortium (SMC)

    Oct 1, 2017, 00:00

  • Análisis De Variabilidad En Los Precios De Servicios En Salud Para Colombia

    Oct 1, 2017, 00:00

  • Identifying The Primary Outcome For A Randomised Controlled Trial In Rheumatoid Arthritis- The Role of A Discrete Choice Experiment

    Oct 1, 2017, 00:00

  • Mapping the Modified Ashworth Scale and Physician’s Global Assessment to Preference-Based Health Utilities in Adults with Lower Limb Spasticity

    Oct 1, 2017, 00:00

  • Concept of Pharmaceutical Care In The Brazilian Legislation

    Oct 1, 2017, 00:00

  • The Patient-Reported Disease Burden In Adults With Atopic Dermatitis- A Cross-Sectional Study In Canada and Europe

    Oct 1, 2017, 00:00

  • IS TRANSTHEORETICAL MODEL’S STAGES OF CHANGE A GOOD PREDICTOR OF MEDICATION ADHERENCE IN PATIENTS WITH TYPE 2 DIABETES?

    Oct 1, 2017, 00:00

  • Costs And Life Expectancy Increased Among Patients With Breast Cancer Across Two Time Periods

    Oct 1, 2017, 00:00

  • Qualitative Exploration of the Real-World Experiences of Men Receiving or Refusing Chemotherapy (Docetaxel) for the Treatment of Metastatic Hormone-Sensitive Prostate Cancer (MHSPC)

    Oct 1, 2017, 00:00

  • A Framework for the Cost-Effectiveness Analysis of Novel Biomarker Testing in Cardiovascular Disease

    Oct 1, 2017, 00:00

  • Direct Oral Anticoagulants Versus Low-Molecular-Weight Heparins for Venous Thromboembolism Prevention Following Total Knee Replacement- Comparative Effectiveness and Medical Costs from a French Nationwide Cohort Study of Around 60,000 Patie ...

    Oct 1, 2017, 00:00

  • Plaque Psoriasis In Bulgaria- Comparative Analysis and Health Technology Assessment

    Oct 1, 2017, 00:00

  • Burden Of Endometriosis And Related Symptoms In A Nationwide Health Plan With 2 Million Members

    Oct 1, 2017, 00:00

  • Implementation Of A Societal Cost-Effective Model Of A Swiss Canton School Vaccination Campaign Through A Hospital Pharmacy Logistics Platform

    Oct 1, 2017, 00:00

  • Cost Effectiveness of Optifast® LCD As Compared with Liraglutide 3 Mg And “No Intervention” In Switzerland

    Oct 1, 2017, 00:00

  • The Comparative Performance of the CHU-9D and Adqol Amongst Children Aged 5 Years or More with Eczema- Evidence from the Clothes Randomised Controlled Trial

    Oct 1, 2017, 00:00

  • Cost –Effectiveness of Obinutuzumab As Frontline Treatment For Unfit Patients With Chronic Lymphocytic Leukemia In Republic of Macedonia

    Oct 1, 2017, 00:00

  • Subjective Financial Burden Among German Cancer Patients - Relationship Of The Patients’ Economic Situation And Subjective Distress

    Oct 1, 2017, 00:00

  • Title- Modelling The Effect of Syphilis Screening At The Entry Point in Chilean Prisons

    Oct 1, 2017, 00:00

  • Baseline Population Characteristics And The Association Between Progression-Free Survival And Overall Survival In Advanced Non-Small Cell Lung Cancer Patients

    Oct 1, 2017, 00:00

  • Health-Related Quality of Life in Moderate-to-Severe Plaque Psoriasis Patients in Brazil

    Oct 1, 2017, 00:00

  • A Cost-Of-Illness Analysis For Community Acquired Pneumonia In Greece

    Oct 1, 2017, 00:00

  • Economic Burden of Immune Thrombocytopenia (ITP) In Patients Receiving Eltrombopag (EPAG) And Romiplostim (ROMI)- Real World Evidence From 26 US Institutions

    Oct 1, 2017, 00:00

  • Quality-Adjusted Life Year (QALY) Losses Associated With Herpes Zoster And Postherpetic Neuralgia In Immunocompromised (IC) and IC-FREE Individuals AGED ≥50 Years of Age, In The Uk Population

    Oct 1, 2017, 00:00

  • Understanding Health Technology Assessment Outcomes For Products With Conditional Market Authorisation In Fran Initial Evaluation VS. Re-Assessment

    Oct 1, 2017, 00:00

  • Cross Border Reproductive Care- Profile and Incentives of Women Travelling to Greece for IVF Treatment

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Posaconazole in Private and Public Brazilian Hospitals

    Oct 1, 2017, 00:00

  • Health and Economic Benefits of Using Single Versus Multiple Inhalers in Patients with Asthma- A Systematic Literature Review

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis Of Tigecycline In Comparision With Imipenem/Cilastatin Or Piperacillin/Tazobactam In The Treatment Of Complicated Intra-Abdominal Infections- A Perspective Of Iranian Health Systems

    Oct 1, 2017, 00:00

  • Assessing Criteria for Nice Recommendation With The Hst Programme

    Oct 1, 2017, 00:00

  • The Effect Of Nsaids On Myocardial, Vascular And Renal Risk Categories-Systematic Review Of Randomized Controlled Trial And Observational Studies

    Oct 1, 2017, 00:00

  • CYP2C19 Guided Antiplatelet Therapy- A Cost-Effectiveness Analysis of 30-Day and One-Year Outcomes Following Percutaneous Coronary Intervention

    Oct 1, 2017, 00:00

  • The Effect of Smoking Cessation Interventions in Patients with Copd- A Systematic Review

    Oct 1, 2017, 00:00

  • A Comparative Review of Value Assessment Frameworks In Germany, France, England, Australia, and South Korea- An Industry Perspective

    Oct 1, 2017, 00:00

  • Regional Variations In Appraisal And Uptake Of New Treatments For Ultra Rare Diseases In The UK- A Case Study Of Ataluren For Nonsense Mutation Duchenne Muscular Dystrophy (NMDMD)

    Oct 1, 2017, 00:00

  • Sensitive Skin In Fran Updated Epidemiological Data

    Oct 1, 2017, 00:00

  • A Cost Per Responder Analysis of Secukinumab Vs. Adalimumab Based on a Matching-Adjusted Indirect Comparison of Efficacy Data for the Treatment of Ankylosing Spondylitis at 52 Weeks from the Irish Payer Perspective

    Oct 1, 2017, 00:00

  • Treatment Patterns In Head Neck Squamous Cell Cancer In Fran Artiste Study on Cancerology Patient Charts

    Oct 1, 2017, 00:00

  • Incidence and Prevalence of Epilepsy in Germany

    Oct 1, 2017, 00:00

  • Validation Of The EQ-5D-5L In Patients With Hip Or Knee Osteoarthritis

    Oct 1, 2017, 00:00

  • The First Five Months Of National Prescription Monitoring In Finland

    Oct 1, 2017, 00:00

  • Avaliação Da Redução De Rehospitalização Dos Pacientes Com Esquizofrenia, Tratados com Palmitato De Paliperidona

    Oct 1, 2017, 00:00

  • Patient Characteristics and Treatment Patterns in Chronic Heart Failure- Results from a Multinational Real-World Cross Sectional Survey

    Oct 1, 2017, 00:00

  • Different Methods for Modelling Severe Hypoglycaemic Events- Implications for Effectiveness and Cost-Effectiveness Analyses

    Oct 1, 2017, 00:00

  • Secukinumab Vs. Adalimumab for Treatment of Ankylosing Spondylitis- A Cost Per Responder Analysis at 52 Weeks from an Argentinian Perspective

    Oct 1, 2017, 00:00

  • Comparative Efficacy And Safety of Olaparib 400 Mg Capsules Bid And Niraparib 300 Mg Tablets QD As Maintenance Treatment After Response To Chemotherapy In Patients with Platinum-Sensitive Relapsed Non-Germline BRCA-Mutated Ovarian Cancer (P ...

    Oct 1, 2017, 00:00

  • Analysis of Effectiveness Criteria In Pharmacoeconomic Studies of Antimicrobial Therapeutic Agents Proposed for Inclusion In The Essential Drug List (RUSSIA) In 2014-2016

    Oct 1, 2017, 00:00

  • Budget Impact of A Supra-Ciliary Micro-Stent In Both Stand-Alone Surgery And In Combination With Cataract Surgery For Primary Open-Angle Glaucoma From A UK Secondary Care Perspective

    Oct 1, 2017, 00:00

  • Comparative Study Of Healthcare Resource Utilization (HRU) Outcomes Between Chronic Lymphocytic Leukemia (CLL) Patients Treated With Ibrutinib Versus Non-Ibrutinib Treated Patients

    Oct 1, 2017, 00:00

  • Observed Reduction of Healthcare Utilization after Omalizumab Initiation Among Patients with Persistent Asthma Followed in Canadian Clinical Settings

    Oct 1, 2017, 00:00

  • Report of Low Density Lipoprotein (LDL) Levels in Patients Diagnosed Whit Hipertension, Diabetes Mellitus and Chronic Kidney Disease in Colombian Population

    Oct 1, 2017, 00:00

  • Epidemiology of BRAFV600-Mutated Metastatic Melanoma In Europe- A Systematic Review

    Oct 1, 2017, 00:00

  • Pharmacoeconomic Analysis Of Dalbavancin Use In Acute Bacterial Skin And Soft Tissue Infections

    Oct 1, 2017, 00:00

  • Short-Term Direct And Indirect Cost Burden of Cardiovascular Events In Patients With A History of Atherosclerotic Cardiovascular Disease In The US

    Oct 1, 2017, 00:00

  • Using Convergent Mixed Methods To Evaluate Treatment Risks and Benefits In Rare Disease- An Example From A Phase Ii Registration Trial In Metastatic Merkel Cell Carcinoma

    Oct 1, 2017, 00:00

  • Adherence To Treatment, Healthcare Resource Use And Costs Related To HIV Patients With Treated With

    Oct 1, 2017, 00:00

  • The Economic Burden of Varicella in Peru

    Oct 1, 2017, 00:00

  • Avanços Do Monitoramento Do Horizonte Tecnológico No Brasil

    Oct 1, 2017, 00:00

  • Hepatoprotective Effect Of Herbal Remedy With Anti-Tuberculosis Treatment

    Oct 1, 2017, 00:00

  • Public Health Expenditure In Patients With Non-Hodgkin's Lymphoma In Mexican Institutions

    Oct 1, 2017, 00:00

  • Budget Impact Analysis Comparing Blinatumomab In The Treatment Of Adults With Philadelphia Chromosome-Negative Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia (All) With Flag-Ida And Hyper CVAD

    Oct 1, 2017, 00:00

  • Predicting Quality Adjusted Life Years Using St. George Respiratory Results In Patients With Severe Emphysema Treated with Endobronchial Coils In Addition To Standard of Care Compared To Standard of Care Alone

    Oct 1, 2017, 00:00

  • The Development Of Acute And Chronic Inpatient Bed Capacities In Neurological, Neurosurgical And Psychiatric Professions Between 2002 And 2016 In Hungary

    Oct 1, 2017, 00:00

  • Alcohol Use and Related Health Problems Among Ethiopian Adults in Gondar- A Cross Sectional Study

    Oct 1, 2017, 00:00

  • Drug Utilization Study Of Antibacterial In The Medical Intensive Care Unit (Micu) Of A Chitwan Medical College Teaching Hospital(Cmcth), Bharatpur, Chitwan, Nepal

    Oct 1, 2017, 00:00

  • Lifelong Apixaban Treatment Is Cost-Effective For The Prevention of Venous Thromboembolism In The Netherlands

    Oct 1, 2017, 00:00

  • Differences In Labour Participation Between People Living With HIV And The General Population- Results From Spain Along The Business Cycle

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Diagnosis- from Tests to Long-Term Outcomes and Costs

    Oct 1, 2017, 00:00

  • The Role Of General Practitioners In Diagnostic Delay In Case Of Cutaneous Malignant Melanoma Patients

    Oct 1, 2017, 00:00

  • Cost Per Response for Abatacept Compared with Adalimumab In the Treatment of Patients with Rheumatoid Arthritis Based on Anti-Citrullinated Protein Antibody Titres In Italy

    Oct 1, 2017, 00:00

  • Racial Differences In The Prevalence of Cognitive Impairments And Dementia, Utilization of Chemo-Immunotherapy and Mortality In Elderly Diffuse Large B-Cell Lymphoma Patients

    Oct 1, 2017, 00:00

  • The Arrival Of Therapeutic Biosimilars In Oncology- The Case Of Trastuzumab

    Oct 1, 2017, 00:00

  • Bypassing Agents Prophylaxis In Patients With Haemophilia And Inhibitors Undergoing Surgery- A Decision Analysis In Spain

    Oct 1, 2017, 00:00

  • Cost Consequence of Introducing Paliperidone Palmitate 3-Monthly For The Maintenance Treatment of Schizophrenia In The English National Health Service (NHS)

    Oct 1, 2017, 00:00

  • Estimating The Number of Relapsed And Refractory Indolent Lymphoma Patients Across Europe, Who Are Expected To Initiate A New Line of Therapy (LOT)

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of A Physical Activity Promotion Intervention For People With Disabilities- A Markov Model Approach

    Oct 1, 2017, 00:00

  • Direct Medical Costs Of Hypoglycemia Hospitalizations In The United States

    Oct 1, 2017, 00:00

  • The Study On Expression of Ap-1 Signaling Pathway and Polymorphisms Of Sep15 and Trxr-2 Genes In Kashin-Beck Disease

    Oct 1, 2017, 00:00

  • Multi-Disciplinary Decision Making In General Practice- A Case Study Of Switching Between Oral Anticoagulants

    Oct 1, 2017, 00:00

  • Therapy Adherence in Asthma – Assessment of Potential Adherence Barriers

    Oct 1, 2017, 00:00

  • Cost Comparison of Licensed Intravitreal Therapies For Diabetic Macular Edema That Responds Insufficiently To Intravitreal Anti-Vegf – A German 3 Year Cost Model

    Oct 1, 2017, 00:00

  • Single Armed Observational Data To Closing The Gap In Otherwise Disconnected Evidence Networks

    Oct 1, 2017, 00:00

  • Minimal Impact on Patients’ Health Utilities Associated with Adverse Events in Metastatic Merkel Cell Carcinoma Patients on Treatment with Avelumab

    Oct 1, 2017, 00:00

  • Older Adults’ Views On Incorporating Life Expectancy In Screening Choices – Results From A National Survey Using A Discrete-Choice Experiment

    Oct 1, 2017, 00:00

  • Risk Sharing Agreements As Payment Mechanisms- A Comprehensive And Communicable Practical Approach For Stakeholders

    Oct 1, 2017, 00:00

  • Self-Perceived Health in Latin America- Results from 2007-2008 Gallup World Poll

    Oct 1, 2017, 00:00

  • Development And Content Validity Testing Of An Assessment Of Symptoms And Experiences Of Patients With Acute Pancreattis Associated With Severe Hypertriglyceridemia

    Oct 1, 2017, 00:00

  • Ankylosing Spondylitis Limits Patients’ Ability to Contribute to Society As Part of the Workfor Results from A Multi-National Survey Including Latin America

    Oct 1, 2017, 00:00

  • Estimating The Public Economic Impact Of Different Hepatitis C Healthcare Policies In The Netherlands

    Oct 1, 2017, 00:00

  • Estimating Life Years And Quality-Adjusted Life Years In Heavily Treatment-Experienced (HTE) Patients

    Oct 1, 2017, 00:00

  • Cost Analysis Of Delivery Neonatal Drug Therapy Services At Ministry Of Health In Saudi Arabia

    Oct 1, 2017, 00:00

  • Effect of Vitamins in Prevention of Alzheimer’s Development- A Meta-Analysis of Randomized Controlled Trials

    Oct 1, 2017, 00:00
  • «
  • 61
  • 62
  • 63
  • 64
  • 65 (current)
  • 66
  • 67
  • 68
  • 69
  • 70
  • »